Informed Prostate Cancer Patient Support

Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT | Radiation Oncology | Full Text

Personalization of Treatment Intensity for Intermediate-Risk Prostate Cancer - International Journal of Radiation Oncology, Biology, Physics

Implementation of a prostate cancer‐specific targeted sequencing panel for credentialing of patient‐derived cell lines and genomic characterization of patient samples - Stover - - The Prostate - Wiley Online Library : Background Primary and metastatic prostate cancers have low mutation rates and recurrent alterations in a small set of genes, enabling targeted sequencing of prostate cancer-associated genes as an e...

NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer | Prostate Cancer and Prostatic Diseases

New blood test combined with image-based prostate cancer screening reduces harms and costs -- ScienceDaily

Genetic Risk Score Prevents Unnecessary Prostate Cancer Workups

Prostate Cancer: a comparison of focal therapy and radical prostatectomy | Prostate Cancer and Prostatic Diseases